Development of Potent and Selective PfCLK3 Inhibitors Based on GSK-TCMDC151 as a New Class of Antimalarials
暂无分享,去创建一个
A. Tobin | Amit Mahindra | A. Jamieson | O. Janha | Kopano Mapesa | A. Sanchez-Azqueta | Mahmood M. Alam | M. M. Alam | A. Sánchez-Azqueta